Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma

WANG Xiang; WANG Xiao-qing; LUO Kai; BAI He; QU Jia-lin; ZHANG Gui-xin

doi:10.1007/s11655-024-4203-9

Your Location：

Home >

Browse articles >

Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma

Review | Updated：2025-01-21

- Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma
- Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma
- 中国结合医学杂志（英文版） 2025年31卷第2期页码：170-182
- Affiliations：
  
  1.Department of General Surgery, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province (116027), China
  2.Clinical Laboratory of Integrative Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province (116021), China
  3.Hepatobiliary Surgery Department, Shandong Provincial Third Hospittal, Shandong University, Jinan (250031), China
  4.Institute (College) of Integrative Medicine, Dalian Medical University, Dalian, Liaoning Province (116044), China
- Author bio：
  
  Prof. ZHANG Gui-xin, E-mail: zhangguixin2024@163.com
- Funds：
  
  the Grants from the National Natural Science Foundation of China(82174136);Dalian Medical University Intensified Program of Wellness Interdisciplinary Research Cooperation Project Team Funding(JCHZ2023004)
- DOI：10.1007/s11655-024-4203-9
  中图分类号：
- 纸质出版日期：2025-02，
  
  网络出版日期：2024-10-29，
  
  录用日期：2024-07-16
- Accepted：
Scan QR Code
Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma[J]. 中国结合医学杂志（英文版）, 2025,31(2):170-182.

WANG XIANG, WANG XIAO-QING, LUO KAI, et al. Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma. [J]. Chinese journal of integrative medicine, 2025, 31(2): 170-182.
Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma[J]. 中国结合医学杂志（英文版）, 2025,31(2):170-182. DOI： 10.1007/s11655-024-4203-9.

WANG XIANG, WANG XIAO-QING, LUO KAI, et al. Research Progress of Chinese Medicine Monomers in Treatment of Cholangiocarcinoma. [J]. Chinese journal of integrative medicine, 2025, 31(2): 170-182. DOI： 10.1007/s11655-024-4203-9.

摘要

Abstract

Cholangiocarcinoma (CCA) is a malignant tumor originating from cholangiocytes. However

it remains unclear about the pathogenesis of this carcinoma

which may be related to multiple factors. Currently

CCA is mainly treated by surgery

chemotherapy

and radiotherapy. Among them

surgery is the only potentially curative option for CCA. Nevertheless

the high malignancy and asymptomatic nature of CCA may lead to poor treatment outcomes. It has been demonstrated that Chinese medicine (CM) plays a significant role in various antitumor applications. Meanwhile

CM exhibits fewer side effects and high availability. Moreover

the

in vitro

application of CM monomers has been explored in many domestic and foreign studies. This article mainly reviews

the signaling pathways and molecular mechanisms of CM monomers in the treatment of CCA in recent years. These findings are expected to provide new insights into the treatment of CCA.

关键词

Keywords

cholangiocarcinomaChinese medicinemonomersantitumorsignaling pathwaysmolecular mechanismsreview

references

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Pharmacological Mechanism of Chinese Medicine in Systemic Lupus Erythematosus: A Narrative Review

Targeting Therapeutic Windows for Rheumatoid Arthritis Prevention

Progress on Regulation of NLRP3 Inflammasome by Chinese Medicine in Treatment of Ulcerative Colitis

Mechanism Study on Chinese Medicine in Treatment of Nodular Goiter

Research on Mechanisms of Chinese Medicines in Prevention and Treatment of Postoperative Adhesion